Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
InnoCare initiated a Phase III registrational trial in China for ICP-332, a TYK2 inhibitor, targeting atopic dermatitis (AD).
InnoCare initiated a Phase III registrational trial in China for ICP-332, a novel TYK2 inhibitor, targeting atopic dermatitis (AD).